MedTrace Logo

Extracolonic Findings on Computed Tomography (CT) Colonography

NCT01465425 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2018-10-11

No results posted yet for this study

Summary

The ACRIN 7151 trial will use medical records abstraction data from participants with extracolonic findings (ECFs) reported from the ACRIN 6664 National CT Colonography Trial to: 1) measure incidence of diagnostic imaging, hospitalization, and interventional procedures associated with ECFs reported on computed tomography colonography (CTC), delineated by type of ECF; 2) determine potential predictors of follow-up diagnostic imaging, hospitalization, and interventional procedures, delineated by type of ECF; and 3) evaluate the clinical/pathologic diagnoses associated with indeterminate but potentially significant ECFs. These data can be used to incorporate ECFs into existing models on the cost-effectiveness of CTC in colorectal cancer screening and can potentially be used to develop guidelines for the reporting and management of ECFs.

Conditions

  • Solitary Pulmonary Nodules
  • Multiple Pulmonary Nodules
  • Renal Neoplasms
  • Adrenal Gland Neoplasms
  • Aortic Aneurysm, Abdominal
  • Liver Neoplasms
  • Adnexal and Skin Appendage Neoplasms
  • Lymphadenopathy
  • Pancreatic Neoplasms

Sponsors & Collaborators

  • American College of Radiology Imaging Network

    lead NETWORK

Principal Investigators

  • Hanna M. Zafar, MD, MHS · University of Pennsylvania

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01465425 on ClinicalTrials.gov